Developer of cannabis-based therapeutics intended to treat various disease conditions.
MIRA1a Therapeutics has raised $625K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2022.
MIRA1a Therapeutics is headquartered in Baltimore, United States.
Developer of cannabis-based therapeutics intended to treat various disease conditions.
MIRA1a Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MIRA1a Therapeutics — Funding & Investors." VCBacked, August 1, 2022, https://www.vcbacked.co/company/mira1a-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). MIRA1a Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mira1a-therapeutics
{{cite web |title=MIRA1a Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mira1a-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated